Russia still expects to ink deal with Astra Zeneca for Covid-19 vaccine
Russia still expects to conclude a deal with AstraZeneca to manufacture the Covid-19 vaccine that it is working on with Oxford University.
AstraZeneca
12,114.00p
13:00 03/05/24
FTSE 100
8,210.34
13:00 03/05/24
FTSE 350
4,511.47
13:00 03/05/24
FTSE All-Share
4,464.86
13:00 03/05/24
GSK
1,728.50p
13:00 03/05/24
Pharmaceuticals & Biotechnology
23,169.05
12:59 03/05/24
In an interview with Reuters, Kirill Dmitriev, the head of the Russian Direct Investment Fund, said he still expected such a deal to go through, despite allegations that Moscow had tried to steal research data by hacking into the computer networks of scientific institutes around the world.
British intelligence ascribed a 95% probability to the chance of the hackers being linked to the Russian state.
Indeed, such a deal might be announced later on Friday, he said.
"There's nothing that needs to be stolen [...] It's all going to be given to Russia."